United Kingdom· GB-APID-37979411000001103
Anoro Ellipta 55micrograms/dose / 22micrograms/dose dry powder inhaler
A medicinal product containing umeclidinium bromide + vilanterol, registered in United Kingdom by Pharmaram Ltd.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Umeclidinium bromide + Vilanterol
- Manufacturer
- Pharmaram Ltd
- Country
- United Kingdom (GB)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin05060666560008
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Umeclidinium bromide + vilanterol in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainANORO ELLIPTA 55 MCG/22 MCG POLVO PARA INHALACION (UNIDOSIS)Glaxosmithkline (Ireland) Limited
- FinlandANORO ELLIPTAOrifarm Oy
- SwedenANORO ELLIPTA 55 mikrogram/22 mikrogram Inhalationspulver, avdelad dosGlaxoSmithKline Trading Services Ltd
- SwitzerlandAnoro Ellipta
- NetherlandsAnoro Ellipta 55 microgram/22 microgram inhalatiepoeder, voorverdeeldGlaxoSmithKline Trading Services Limited
- PolandAnoro ElliptaGlaxoSmithKline (Ireland) Limited
- CanadaANORO ELLIPTAGLAXOSMITHKLINE INC
- NorwayAnoro ElliptaGlaxoSmithKline (Ireland) Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Anoro Ellipta, Laventair Ellipta
- Liechtenstein · Anoro Ellipta, Laventair Ellipta
- Norway · Anoro Ellipta, Laventair Ellipta
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/edf7d8de-5fe2-4e0c-b073-530164ed9818 GET /v1/drugs/edf7d8de-5fe2-4e0c-b073-530164ed9818?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "37979411000001103",
"desc": "Anoro Ellipta 55micrograms/dose / 22micrograms/dose dry powder inhaler (Pharmaram Ltd)",
"form": "Inhalation powder",
"vpid": "24645511000001105",
"source": "dmd",
"vtm_id": "24645211000001107",
"strength": "22 microgram",
"substance": "Umeclidinium bromide + Vilanterol",
"ingredient": "Vilanterol trifenatate",
"supplier_code": "36811311000001106"
}See everything about umeclidinium bromide + vilanterol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.